Korsana Biosciences vs NRX Pharmaceuticals
KRSA and NRXP side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KRSA and NRXP compare
Korsana Biosciences is the larger company, worth 1.6 times as much as NRX Pharmaceuticals ($153M against $93.1M).
Korsana Biosciences keeps more of each dollar of sales as profit, with a net margin of −353% compared with −692% at NRX Pharmaceuticals.
Korsana Biosciences scores higher on the StockData Score (6 against 0 for NRX Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KRSA | NRXP |
|---|---|---|
| Size and price | ||
| Market cap | $153M | $93.1M |
| Share price | $32.68 | $2.15 |
| Change, 1 year | 224% | −17.0% |
| Change, 5 years | −90.5% | −96.8% |
| Beta (5Y) | 5.72 | 1.35 |
| Employees | 1 | 29 |
| StockData Score | ||
| Total score | 6 (better) | 0 |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 4 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 80.5× | 27.4× (better) |
| P/B | 30.1× | – |
| Fair value | $5.47 | – |
| Margin of safety | −498% | – |
| Growth | ||
| Revenue growth (TTM) | −12.6% | – |
| Revenue growth, 5Y average | −2.0% | – |
| Profitability | ||
| Gross margin | – | 46.6% |
| Operating margin | −359% (better) | −586% |
| Net margin | −353% (better) | −692% |
| Return on equity | −98.2% | – |
| Return on invested capital | −116% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −17.4× |
| Current ratio | 0.82 | 0.86 (better) |
| Altman Z-score | −8.97 (better) | −13.67 |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 15.1% | 26.9% |
| Held by insiders | – | 15.6% |
| Short interest, % of float | – | 28.6% |
Go deeper
- KRSA stock overview
- KRSA income statement
- KRSA valuation and score
- NRXP stock overview
- NRXP income statement
- NRXP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.